scm logo

SCM Life Science Co., Ltd. (hereinafter referred to as SCM Life Science, CEO Lee Byung-gun) signed a joint research agreement on tissue regeneration treatments that directly transplants single cell-derived clone stem cell sheets into tissues using “Subfractionation Culturing Method” (CSTEC) in Utah University's healthcare system local time on the 10th.

SCM Life Science is a stem cell therapy company with original technology in the field of high-purity isolation and culture of adult stem cells. And The Cell Sheet Tissue Engineering Center (CSTEC), an integrated research team at Utah University Medical School and Pharmacy that developed heart disease treatments based on cell sheet tissue engineering, has signed a joint research agreement to develop and function in the U.S.

"Our research team is focusing on the development of stem cell sheet tissue engineering technology for regenerative treatment," said Teruo Okano, head of the CSTEC center. "We want to develop innovative treatments for many patients around the world who need regenerative treatment through the convergence of high-purity mesenchymal stem cell and cell sheet tissue engineering technology using SCM Life Science."

We plan to provide technology and funding for CSTEC's joint research on cell sheet tissue engineering, said Lee Byung-gun, CEO of SCM Life Science. "We hope to develop new technologies that combine mutual technologies to lead new regenerative medicine through successful clinical and commercialization."

Meanwhile, SCM Life Science is focusing on the development of next-generation stem cell treatments for autoimmune diseases, an intractable disease, and has continued research for more than 10 years based on its own source technology for adult mesenchyma stem cell separation and culture. Through this, patents have been registered in major countries, including the United States, the EU, Japan, and China, and are currently focusing on developing cell therapies such as chronic and acute Graft versus host disease (GVHD), severe acute pancreatitis, severe atopic dermatitis, and severe cirrhosis.